Gainers Aethlon Medical (NASDAQ:AEMD) shares increased by 382.5% to $6.9 during Thursday's pre-

Gainers Tempest Therapeutics (NASDAQ:TPST) stock increased by 41.6% to $1.07 during Tuesday's a

Gainers PDS Biotechnology (NASDAQ:PDSB) shares rose 63.7% to $0.65 during Tuesday's regular ses

Gainers Circle8 Group (NASDAQ:CIRC) stock moved upwards by 14.6% to $0.57 during Monday's after

NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &

Bio Green Med Solution (NASDAQ:BGMS) reported quarterly losses of $(0.08) per share. This is a 91.4

KUALA LUMPUR, MALAYSIA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

Gainers Matinas BioPharma Hldgs (AMEX:MTNB) shares increased by 59.7% to $0.39 during Monday's

Forte Biosciences shares rose 38.9% to $76.10 in pre-market trading after argenx SE announced plans

Cyclacel Pharmaceuticals (NASDAQ: BGMS - Get Free Report) and Peak Pharmaceuticals (OTCMKTS:PKPH - G

Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday&#

Bio Green Med Solution, Inc. (NASDAQ:BGMS) shares are trading higher Friday after the company announ

Bio Green Med Solution (NASDAQ: BGMS) shares are trading higher Friday after it announced a Business

TTAN: 18% | ServiceTitan shares are trading higher after the company reported better-than-expected Q

Solidion Technology, Inc. (NASDAQ: STI) rose 50.55% in pre-market trading on Friday after announcing

Bio Green Med Solution shares jumped 148.10% after-hours on business combination deal with Future NR

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merge

Bio Green Med Solution, Inc. (NASDAQ:BGMS, the "Company")) today announced that it entered i

Creation of a next-generation environmental platform: The proposed transaction brings together essen

Cyclacel Pharmaceuticals (NASDAQ:BGMS) reported quarterly losses of $(0.04) per share. This is a 99.

KUALA LUMPUR, MALAYSIA, May 14, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS;

Bio Green Med Solution (NASDAQ:BGMS) reported quarterly losses of $(2.21) per share. This is a 99.74

KUALA LUMPUR, MALAYSIA, March 30, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. ("BGMS," the

Syros Pharmaceuticals (NASDAQ: SYRS - Get Free Report) and Cyclacel Pharmaceuticals (NASDAQ: BGMS -

Cyclacel Pharmaceuticals (NASDAQ: BGMS - Get Free Report) and Achaogen (OTCMKTS:AKAOQ - Get Free Rep

Calliditas Therapeutics AB (publ) (NASDAQ: CALT - Get Free Report) and Cyclacel Pharmaceuticals (NAS

Bio Green Med Solution (NASDAQ:BGMS) reported quarterly losses of $(1.31) per share. This is a 51.48

KUALA LUMPUR, Malaysia, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS